• INTRODUCTION
  • Objective and methods
  • Definition and diagnostic criteria
  • Differential diagnosis
  • Catatonia and delirium
  • Malignant catatonia
• PEDIATRIC CATATONIA
  • Introduction
  • Occurrence
  • Co-occurrence with Autism Spectrum Disorder
  • Assessment and Rating Scales
  • Treatment of Pediatric Catatonia
• ADULT CATATONIA
  • Occurrence and Etiology
• MEDICAL CONDITIONS ASSOCIATED WITH CATATONIA
  • Anti-NMDA-receptor Encephalitis (ANRE)
  • Paraneoplastic Limbic Encephalitis
  • Systemic Lupus Erythematous (SLE)
  • Seizures
  • Brain infections
  • Intracranial Mass Lesions
  • Multiple Sclerosis
  • Delirium (Encephalopathy)
  • Glucose-6-phosphate dehydrogenase (G6PD) Deficiency
  • Vitamin B12 Deficiency
  • Hyponatremia
  • Stroke, Dementia, and Other Brain Degeneration Disorders
  • Takotsubo Cardiomyopathy
  • Wilson's Disease
  • Special Note on Ferropenia
• DRUG TOXIDROMES AND WITHDRAWAL SYNDROMES ASSOCIATED WITH CATATONIA
  • Tacrolimus and Cyclosporine
  • 3,4-methylenedioxy-N-methylamphetamine (MDMA)
  • Steroids
  • Antibiotics
  • Disulfiram
  • GABA agonist withdrawal
  • Baclofen
  • Dopamine antagonists
  • Cocaine withdrawal
  • Phencyclidine (PCP)
  • Methoxetamine
• TREATMENT OF CATATONIA
  • GABA agonists
  • NMDA Receptor Antagonists
  • Minocycline
  • Antipsychotics
  • ECT
  • Other Treatments
• CONCLUSIONS

REFERENCES

APPENDIXES

1. Recommended Readings
2. Glossary of Terms
3. Annotated List of Important Pharmacologic Trials
4. Standardized Assessment and Work-Up
   •       Introduction
   •       Proposed Screen for Catatonia in the Medically Ill
   •       Assessment and Examination
   •       Pharmacologic Challenge
   •       Initial Recommendations to the Primary Service
   •       Definitive Treatment

Catatonia in Medically Ill Patients

Main  |  EBM Summary  |  References  |  Appendixes: A B C D